JP2016523285A5 - - Google Patents

Download PDF

Info

Publication number
JP2016523285A5
JP2016523285A5 JP2016522933A JP2016522933A JP2016523285A5 JP 2016523285 A5 JP2016523285 A5 JP 2016523285A5 JP 2016522933 A JP2016522933 A JP 2016522933A JP 2016522933 A JP2016522933 A JP 2016522933A JP 2016523285 A5 JP2016523285 A5 JP 2016523285A5
Authority
JP
Japan
Prior art keywords
composition
composition according
msc
administered
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016522933A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016523285A (ja
JP6412933B2 (ja
Filing date
Publication date
Priority claimed from GB201311290A external-priority patent/GB201311290D0/en
Priority claimed from GB201319004A external-priority patent/GB201319004D0/en
Application filed filed Critical
Priority claimed from PCT/IB2014/062598 external-priority patent/WO2014207679A1/en
Publication of JP2016523285A publication Critical patent/JP2016523285A/ja
Publication of JP2016523285A5 publication Critical patent/JP2016523285A5/ja
Application granted granted Critical
Publication of JP6412933B2 publication Critical patent/JP6412933B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016522933A 2013-06-25 2014-06-25 免疫調節活性を有する細胞集団、その調製方法および使用 Active JP6412933B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB1311290.9 2013-06-25
GB201311290A GB201311290D0 (en) 2013-06-25 2013-06-25 Medical use
GB201319004A GB201319004D0 (en) 2013-10-28 2013-10-28 Medical use
GB1319004.6 2013-10-28
PCT/IB2014/062598 WO2014207679A1 (en) 2013-06-25 2014-06-25 Cell populations having immunoregulatory activity, methods for the preparation and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018186262A Division JP6764912B2 (ja) 2013-06-25 2018-10-01 免疫調節活性を有する細胞集団、その調製方法および使用

Publications (3)

Publication Number Publication Date
JP2016523285A JP2016523285A (ja) 2016-08-08
JP2016523285A5 true JP2016523285A5 (enExample) 2017-08-03
JP6412933B2 JP6412933B2 (ja) 2018-10-24

Family

ID=51257544

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016522933A Active JP6412933B2 (ja) 2013-06-25 2014-06-25 免疫調節活性を有する細胞集団、その調製方法および使用
JP2018186262A Active JP6764912B2 (ja) 2013-06-25 2018-10-01 免疫調節活性を有する細胞集団、その調製方法および使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018186262A Active JP6764912B2 (ja) 2013-06-25 2018-10-01 免疫調節活性を有する細胞集団、その調製方法および使用

Country Status (4)

Country Link
US (1) US20160120910A1 (enExample)
EP (1) EP3013943B1 (enExample)
JP (2) JP6412933B2 (enExample)
WO (1) WO2014207679A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060045872A1 (en) 2004-08-25 2006-03-02 Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco Use of adipose tissue-derived stromal stem cells in treating fistula
PT1926813T (pt) 2005-09-23 2016-09-06 Consejo Superior Investigacion Populações de células que têm atividade imunorreguladora, método para isolamento e usos
EP3160480B1 (en) * 2014-06-30 2020-09-09 TiGenix, S.A.U. Mesenchymal stromal cells for treating rheumatoid arthritis
WO2016170187A2 (en) * 2015-04-24 2016-10-27 Tigenix, S.A.U Biomarkers for determining the clinical response to cell therapy
CN105062967A (zh) * 2015-09-01 2015-11-18 沈慧勇 一种人骨髓间充质干细胞的制备方法及其应用
GB201604304D0 (en) 2016-03-14 2016-04-27 Tigenix S A U Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
IT201700043316A1 (it) * 2017-04-20 2018-10-20 Lipogems Int S P A Drug delivery system
KR102909951B1 (ko) * 2019-02-27 2026-01-07 다케다 파머수티컬 컴패니 리미티드 동종 요법을 위한 개선된 줄기세포 집단
WO2020232940A1 (en) * 2019-05-21 2020-11-26 Emo Biomedicine Corp. Use of mesenchymal stem cells in treating immune-related diseases
CN114395609A (zh) * 2022-02-09 2022-04-26 湖南源品细胞生物科技有限公司 一种具有高免疫调节潜力的人间充质干细胞的筛选方法
EP4623302A1 (en) 2022-11-23 2025-10-01 DRK-Blutspendedienst Baden-Württemberg-Hessen gGmbH Biomarkers predictive of immunomodulatory mesenchymal stromal cells

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ258570A (en) 1992-12-02 1996-06-25 Shell Int Research Azoxycyanobenzene derivatives and plant fungicidal compositions
US5578475A (en) 1993-07-12 1996-11-26 Life Technologies, Inc. Composition and methods for transfecting eukaryotic cells
JP4335310B2 (ja) 1995-06-07 2009-09-30 ザ ユニバーシティ オブ ブリティッシュ コロンビア 疎水性脂質−核酸複合中間体を通して調製される脂質−核酸粒子、及び遺伝子移送のための使用
US6051429A (en) 1995-06-07 2000-04-18 Life Technologies, Inc. Peptide-enhanced cationic lipid transfections
US5744335A (en) 1995-09-19 1998-04-28 Mirus Corporation Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein
US5705308A (en) 1996-09-30 1998-01-06 Eastman Kodak Company Infrared-sensitive, negative-working diazonaphthoquinone imaging composition and element
US20080095749A1 (en) * 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
PT1926813T (pt) * 2005-09-23 2016-09-06 Consejo Superior Investigacion Populações de células que têm atividade imunorreguladora, método para isolamento e usos
DK2205721T3 (en) * 2007-10-17 2016-10-24 Txcell TR1 cells mesenchymal stem cells and uses thereof
WO2011047345A2 (en) * 2009-10-15 2011-04-21 Tai June Yoo Methods of treating diseases of conditions using mesenchymal stem cells
US20140154274A1 (en) * 2011-01-12 2014-06-05 Tigenix Nv Methods and compositions for use in intralymphatic cellular therapies
KR20140016933A (ko) * 2011-03-11 2014-02-10 타이제닉스, 에스.에이.유. 면역조절 활성을 갖는 세포군, 분리방법 및 용도들

Similar Documents

Publication Publication Date Title
JP2016523285A5 (enExample)
Ejtehadifar et al. The effect of hypoxia on mesenchymal stem cell biology
Galderisi et al. The gap between the physiological and therapeutic roles of mesenchymal stem cells
Li et al. Bone‐marrow‐derived mesenchymal stem cells for organ repair
Kariminekoo et al. Implications of mesenchymal stem cells in regenerative medicine
Capelli et al. Minimally manipulated whole human umbilical cord is a rich source of clinical-grade human mesenchymal stromal cells expanded in human platelet lysate
Coulson-Thomas et al. Extrinsic and intrinsic mechanisms by which mesenchymal stem cells suppress the immune system
JP2017520583A5 (enExample)
Rastegar et al. Mesenchymal stem cells: Molecular characteristics and clinical applications
Gang et al. In vitro mesengenic potential of human umbilical cord blood-derived mesenchymal stem cells
Malgieri et al. Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art
JP2016116523A5 (enExample)
Bogdanova et al. Characterization of human adipose-derived stem cells cultured in autologous serum after subsequent passaging and long term cryopreservation
Rahimzadeh et al. Biotechnological and biomedical applications of mesenchymal stem cells as a therapeutic system
JP2014208682A5 (enExample)
JP2015507921A5 (enExample)
WO2018083700A1 (en) Mesenchymal stem cells populations, their products, and use thereof
JP2014509319A5 (enExample)
JP2009508507A5 (enExample)
MX338931B (es) Composiciones y metodo para tratar gliobastoma (gbm).
EA201790025A1 (ru) Создание банка мезенхимальных стромальных клеток из объединенных мононуклеарных клеток нескольких доноров костного мозга
Raafat et al. Mesenchymal stem cells: in vivo therapeutic application ameliorates carbon tetrachloride induced liver fibrosis in rats
Nemeth et al. Bone marrow stromal cells as immunomodulators. A primer for dermatologists
Kim et al. Suppression of in vitro murine T cell proliferation by human adipose tissue-derived mesenchymal stem cells is dependent mainly on cyclooxygenase-2 expression
JP2019508455A5 (enExample)